🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the manufacturers of Tylenol, alleging the companies hid alleged dangers that the drug presented to children's cognitive development.

This legal action comes thirty days after Donald Trump advocated an unproven link between consuming Tylenol - alternatively called paracetamol - during pregnancy and autism spectrum disorder in children.

The attorney general is taking legal action against Johnson & Johnson, which previously sold the drug, the only pain reliever approved for women during pregnancy, and the current manufacturer, which now manufacturers it.

In a official comment, he stated they "misled consumers by making money from suffering and promoting medication regardless of the potential hazards."

The company states there is no credible evidence connecting acetaminophen to autism spectrum disorder.

"These companies deceived for years, deliberately risking countless individuals to boost earnings," the attorney general, from the Republican party, stated.

Kenvue commented that it was "deeply concerned by the perpetuation of misinformation on the security of paracetamol and the possible consequences that could have on the health of American women and children."

On its online platform, the company also stated it had "continuously evaluated the relevant science and there is no credible data that indicates a established connection between taking acetaminophen and autism spectrum disorder."

Organizations representing physicians and healthcare providers concur.

The American College of Obstetricians and Gynecologists has stated paracetamol - the key substance in acetaminophen - is one of the few options for expectant mothers to treat pain and elevated temperature, which can create serious health risks if left untreated.

"In multiple decades of studies on the utilization of paracetamol in pregnancy, no reliable research has conclusively proven that the usage of paracetamol in any trimester of pregnancy leads to neurodevelopmental disorders in children," the group commented.

The lawsuit mentions recent announcements from the Trump administration in arguing the drug is reportedly hazardous.

Recently, the former president raised alarms from medical authorities when he instructed pregnant women to "fight like hell" not to use Tylenol when sick.

The FDA then released a statement that physicians should think about restricting the usage of acetaminophen, while also stating that "a proven link" between the medication and autism spectrum disorder in children has not been proven.

Health Secretary Kennedy, who oversees the FDA, had promised in spring to undertake "a massive testing and research effort" that would determine the origin of autism spectrum disorder in a matter of months.

But specialists cautioned that discovering a sole reason of autism spectrum disorder - believed by scientists to be the result of a complicated interplay of inherited and surrounding conditions - would not be simple.

Autism spectrum disorder is a category of permanent neurological difference and impairment that influences how persons experience and engage with the world, and is diagnosed using doctors' observations.

In his lawsuit, the attorney general - a Trump ally who is seeking US Senate - alleges the manufacturer and J&J "deliberately disregarded and attempted to silence the science" around acetaminophen and autism.

This legal action aims to force the companies "remove any promotional materials" that states Tylenol is reliable for expectant mothers.

This legal action echoes the concerns of a group of guardians of children with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the manufacturers of Tylenol in recently.

Judicial authorities threw out the case, saying investigations from the plaintiffs' authorities was not conclusive.